Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Ret finger protein deficiency attenuates adipogenesis in male mice with high fat diet-induced obesity

Lee YG., Jeong A., Lim Y., Shin S., Joung H., Cho HJ.

Animal Study on Systemic / IV, published in Exp Mol Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Exp Mol Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40968148
PMCID
PMC12508092
DOI
10.1038/s12276-025-01553-7

Abstract (original English)

Ret finger protein (RFP, also known as TRIM27) is a multifunctional E3 ubiquitin ligase implicated in transcriptional regulation. While previously reported to repress myogenesis, its role in adipose tissue metabolism remains unclear. Here, using both global and adipocyte-specific RFP-knockout male mice subjected to high-fat diet feeding, we found that RFP deficiency markedly attenuated body weight gain, adipose tissue expansion and adipocyte hypertrophy, while improving glucose tolerance, insulin sensitivity and circulating lipid profiles. Indirect calorimetry demonstrated significantly increased whole-body energy expenditure, independent of food intake or physical activity. Consistent with these murine findings, RFP expression was elevated in omental adipose tissue from obese human subjects, underscoring the translational relevance. Mechanistic studies revealed that RFP physically interacts with PPAR-γ and enhances its transcriptional activity, thereby promoting expression of adipogenic target genes such as AP2 and adiponectin. Loss of RFP suppressed adipocyte differentiation both in vivo and in vitro. Collectively, our findings identify RFP as a positive regulator of adipogenesis and systemic metabolism via PPAR-γ activation. Genetic ablation of RFP confers resistance to high-fat diet-induced obesity, suggesting that targeting RFP may represent a potential therapeutic strateg

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdipocytesAnimalsMice, Inbred C57BLMice, KnockoutHumansMiceObesityUbiquitin-Protein LigasesPPAR gamma

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research